Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 022224
Company: ABBVIE
Company: ABBVIE
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| TRILIPIX | CHOLINE FENOFIBRATE | EQ 45MG FENOFIBRIC ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE, DELAYED RELEASE;ORAL | Discontinued | None | Yes | No |
| TRILIPIX | CHOLINE FENOFIBRATE | EQ 135MG FENOFIBRIC ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE, DELAYED RELEASE;ORAL | Discontinued | None | Yes | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 12/15/2008 | ORIG-1 | Approval | Type 2 - New Active Ingredient | STANDARD |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022224s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022224s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022224_trilipix_toc.html https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022224s000_SumR.pdf |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 06/06/2025 | SUPPL-18 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022224s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/021656s032,022224s018ltr.pdf | |
| 06/03/2021 | SUPPL-17 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022224s016s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/022224Orig1s016, s017; 021656Orig1s030, s031ltr.pdf | |
| 06/03/2021 | SUPPL-16 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022224s016s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/022224Orig1s016, s017; 021656Orig1s030, s031ltr.pdf | |
| 03/28/2019 | SUPPL-15 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022224s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021203Orig1s009, 021656Orig1s029, 022224Orig1s015ltr.pdf | |
| 11/07/2018 | SUPPL-14 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022224s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/022224Orig1s014ltr.pdf | |
| 05/18/2018 | SUPPL-13 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022224s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/022224Orig1s013ltr.pdf | |
| 11/18/2015 | SUPPL-12 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 04/27/2015 | SUPPL-11 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022224Orig1s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022224Orig1s011ltr.pdf | |
| 04/17/2015 | SUPPL-10 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 01/28/2013 | SUPPL-9 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 09/05/2012 | SUPPL-8 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022224s007s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/022224Orig1s008ltr.pdf | |
| 09/05/2012 | SUPPL-7 | Manufacturing (CMC) |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022224s007s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/022224Orig1s008ltr.pdf | |
| 09/30/2011 | SUPPL-6 | REMS-Assessment, REMS-Modified |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022224s005s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022224s005,s006ltr.pdf | |
| 09/30/2011 | SUPPL-5 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022224s005s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022224s005,s006ltr.pdf | |
| 03/14/2011 | SUPPL-4 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022224s004ltr.pdf |
| 09/14/2010 | SUPPL-3 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022224s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022224s003ltr.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 06/06/2025 | SUPPL-18 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022224s018lbl.pdf | |
| 06/03/2021 | SUPPL-17 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022224s016s017lbl.pdf | |
| 06/03/2021 | SUPPL-16 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022224s016s017lbl.pdf | |
| 03/28/2019 | SUPPL-15 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022224s015lbl.pdf | |
| 11/07/2018 | SUPPL-14 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022224s014lbl.pdf | |
| 05/18/2018 | SUPPL-13 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022224s013lbl.pdf | |
| 04/27/2015 | SUPPL-11 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022224Orig1s011lbl.pdf | |
| 09/05/2012 | SUPPL-8 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022224s007s008lbl.pdf | |
| 09/05/2012 | SUPPL-7 | Manufacturing (CMC) | Label (PDF) | This supplement type does not usually require new labeling. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022224s007s008lbl.pdf |
| 09/30/2011 | SUPPL-6 | REMS-Assessment | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022224s005s006lbl.pdf | |
| 09/30/2011 | SUPPL-6 | REMS-Modified | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022224s005s006lbl.pdf | |
| 09/30/2011 | SUPPL-5 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022224s005s006lbl.pdf | |
| 09/14/2010 | SUPPL-3 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022224s003lbl.pdf | |
| 12/15/2008 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022224s000lbl.pdf |